Nasdaq News

Unlike wind and solar, geothermal energy is a 24/7 energy resource, but the technologies to explore and drill for resources and build facilities make geothermal energy more expensive than other renewables.

Boosted by better than expected Chinese trade data, global markets were generally higher today with futures up by more than 1% going into North American trade.

March quarter earnings season, which is likely to be the strangest one ever, kicked off this morning, and while only a handful of companies reported results from JPMorgan Chase (JPM) and Johnson & Johson (JNJ) fared better than feared as they wrestle with the pandemic

With the COVID-19 pandemic forcing people to stay at home -- and significantly reducing economic activity -- many businesses are struggling to stay afloat, and will likely continue grappling with the aftermath long after the outbreak ends. As a result, many of these companies wi

If you are going to commit to holding a stock for a long time, then it's a good idea to invest in companies with a secure recurring revenue stream -- that's where dividend aristocrats Ecolab (NYSE: ECL) and Pentair (NYSE: PNR) come in. The third option, Hormel Foods (NYSE: HRL

As coronavirus has spread across the globe, it has left financial devastation in its wake. Besides those affected directly by the contagion, millions of jobs have been lost and businesses have been forced into digital-only operation mode -- if not closed down indefinitely. Suffi

Big pharmaceutical companies and small biotechs alike have jumped into the race to develop treatments and vaccines for the novel coronavirus disease COVID-19. Pfizer (NYSE: PFE) ranks as one of the biggest of the big pharma companies and has several COVID-19 efforts under way. M

For the past year, the marijuana industry has been an absolute train wreck. Since the industry exploded higher during the first quarter of 2019, virtually every pure-play cannabis stock has lost between 50% and 95% of its value.

The S&P 500 has recently started recovering some of its losses after the past six weeks of brutal stock market turmoil in the wake of the COVID-19 pandemic, but the index is still down about 15% compared to where it was at the beginning of the year.

The COVID-19 outbreak hasn't just made thousands of Americans ill; it's also battered the economy to an almost unbelievable degree. Unemployment claims are through the roof, countless small businesses are shut down, and millions of Americans are stressed about the notion of losi

iQiyi (NASDAQ: IQ), which owns of the top video streaming platforms in China, was recently slammed by allegations of fraud by Wolfpack Research. The activist research firm, which prepared the report with prolific short-seller Muddy Waters, claimed that iQiyi inflated its revenu

OTE Telecom will cut expenses drastically to ensure it meets its targets for 2020 earnings before interest, tax, depreciation and amortisation (EBITDA) and free cash flow, the CEO of Greece's biggest telecom operator said on Tuesday.

Indonesia's central bank kept its key interest rate unchanged on Tuesday, but cut the amount of cash banks must keep in reserve to inject liquidity into the financial system and help the economy ride out the coronavirus crisis.

UK stock markets fell on Monday as shares in British American Tobacco slumped on report of a U.S. criminal probe, while signs that Britain will remain under lockdown for a longer period dented the mood.

Stocks advanced globally on Tuesday on signs the world economy is slowly reopening with coronavirus spreading at a decreasing rate.

(RTTNews) - French stocks opened higher on Tuesday as a flattening of the coronavirus curve pointed to the slowing of the spread of the disease globally and solid trade data from China helped ease fears of a deep global recession.

The Philippines introduced a more aggressive testing programme for the coronavirus on Tuesday to locate what it said could be as many as 15,000 unknown infections, despite having implemented some of Asia's strictest and earliest lockdown measures.

Hong Kong shares closed higher on Tuesday after China reported smaller-than-expected contractions in imports and exports in March, and as fears over the global spread of the new coronavirus eased. ** The Hang Seng index ended up 135.07 points or 0.56% at 24,435.40. The Hang Seng China Enterprises index rose 0.37% to 9,847.47. ** The sub-index of the Hang Seng tracking energy shares dipped 1.1%, while the IT sector rose 1.12%, the financial sector ended 0.6% higher and the property sector rose 1.05%. ** China's exports fell 6.6% in March from a year earlier, while imports shrank 0.9%, a better-than-expected outcome as factories restarted production, though the global coronavirus health crisis looks set to keep trade under pressure over coming months. [nB9N2BR00K] ** The top gainer on the Hang Seng was CK Asset Holdings Ltd, which gained 3.76%, while the biggest loser was AAC Technologies Holdings Inc, which fell 3.21%. ** China's main Shanghai Composite index closed up 1.59% at 2,827.28, while the blue-chip CSI300 index ended up 1.93%. ** Around the region, MSCI's Asia ex-Japan stock index was firmer by 1.28%, while Japan's Nikkei index closed up 3.13%. ** The yuan was quoted at 7.0583 per U.S. dollar at 0825 GMT, 0.08% weaker than the previous close of 7.053. ** The top gainers among H-shares were BYD Co Ltd up 3.33%, followed by CITIC Securities Co Ltd, gaining 3.31% and China Conch Venture Holdings Ltd, up by 3%. ** The three biggest H-shares percentage decliners were CNOOC Ltd, which was down 2.69%, PetroChina Co Ltd, which fell 2.68% and Sunny Optical Technology Group Co Ltd, down by 2.31%. (Reporting by Andrew Galbraith; editing by Uttaresh.V) ((Andrew.Galbraith@tr.com; +86 21 2083 0079; Reuters Messaging: andrew.galbraith.thomsonreuters.com@reuters.net ; Twitter: https://twitter.com/apgalbraith)) nAZN18NU00

Australia's jobless rate is forecast to spike to the highest level in a quarter of a century because of the coronavirus pandemic, but officials said on Tuesday it was still too soon to let up on social restrictions that are curbing economic growth.

AstraZeneca Plc said on Tuesday that it would start a clinical trial to assess the potential of Calquence in the treatment of the exaggerated immune response associated with COVID-19 infection in severely ill patients.